Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Jan McAllister
-
j.mcallister@uea.ac.uk


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Management of social anxiety in clients who stutter
Back

Management of social anxiety in clients who stutter

Not Recruiting

Open to: All Genders

Age: Adult

13.9 Mile Away
Norwich

Medical Conditions

Topic: Mental Health Research Network, Primary Care Research Network for England
Subtopic: Anxiety, Not Assigned
Disease: Anxiety, All Diseases

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


About 1% of adults continue to experience stuttering (stammering) that began in childhood. For many of these adults, severe social anxiety (social phobia) is a serious problem. Social phobia involves a fear of situations where the person has to speak to others, in places such as work or education as well as social occasions, or where they fear that others will form negative views of them. This project aims to develop a new treatment for social phobia in adults who stutter. The treatment builds on the observation that, compared with an average person, people who are very socially anxious are more likely to focus on signs of disapproval in others (such as disapproving facial expressions). This tendency to look for negative signals is what causes and maintains the anxiety. Earlier research has shown that this tendency can be corrected by getting people with high levels of social anxiety to take part in a simple computer task. In previous studies, doing the task has lowered occurences of social anxiety disorder. If this treatment is to be used in the NHS for people who stutter, we must first make sure that it works, that it is safe and acceptable to people who use it, and whether it has any other benefits such as improving the speech fluency of people who stutter. We also need to know about its cost to the NHS. The study described here is a first step towards answering these questions.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

03 May 2013 02 Nov 2013

Publications

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29061602 results (added 29/01/2019)

Participants would be randomly allocated to the treatment condition, the computer task (that is, the one that we think may improve social anxiety) or to a placebo (dummy) condition where they carry out a similar-looking computer task. We need to look at how people respond in both conditions because this is the only way that we can tell whether the treatment really works. The simple 5-minute computer task should be performed 8 times in a 4-week period. The task consists of a set of trials. On each trial, the person first sees a pair of faces presented very briefly. The faces then disappear and a letter appears in the place where one of the faces was previously. The person has to press a button as fast as possible to indicate what letter it was. Participants need to visit the University of East Anglia three times in a 5-month period, to have a conversation with a clinically-trained researcher, make a recording of their speech and fill in some questionnaires. Travel expenses up to a maximum of £55 per trip will be paid. If travelling to the University is inconvenient, it may be possible for the researcher to visit the participant instead.


People aged 18 or over who stutter, who are not currently receiving speech treatment for their stutter (and have not been having such treatment in the past 6-12 months). Participants need to meet initial screening criteria about their stutter and their level of social anxiety, and must understand English to a level where they can make informed decisions about the study and understand the task instructions. They should not have been involved in other stuttering or social anxiety research in the previous 12 months. They should not have a mental disability. They should not be taking benzodiazepine medication (for anxiety), and if they are taking other mood-altering medication they need to be willing to continue to take these during the course of the study.

You can take part if:



You may not be able to take part if:


1. Cognitive behavioural therapy (CBT) during the previous 6 months2. Speech treatment during the previous 12 months3. Involvement in stuttering or social anxiety research during the previous 12 months4. Serious risk of self-harm, evaluated during interview at baseline5. Intellectual disability6. Current use of benzodiazepines7. Unwillingness or inability to maintain a stable dose of any extant psychotropic medication for the duration of the trial


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • University of East Anglia
    Norwich
    NR4 7TJ

Participants will receive a £20 gift voucher to thank them for participating. Although an individual participant may not benefit directly from taking part in the study, they would be contributing to the development of a potentially worthwhile treatment for people who stutter. It is possible that participants may become upset when talking about their experience of stuttering with the clinically-trained researcher.

Dr Jan McAllister
-
j.mcallister@uea.ac.uk



The study is sponsored by NHS South Norfolk Clinical Commissioning Group (UK) and funded by NIHR Research for Patient Benefit (RfPB) (UK); Grant Codes: PB-PG-0610-22225.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN55065978

Or CPMS 12924

Last updated 29 January 2019

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top